未登录

韩晓鹏 (Xiaopeng Han)

China Pharmaceutical University药学院，副教授

H指数:24

被引数:2,257

个人简介

任职于中国药科大学药学院，副教授。2015年获沈阳药科大学博士学位。2021年任中南药学青年编委。研究方向为智能纳米制剂技术、口服固体制剂研发与产业化。

教育背景

2011.09 – 2015.07
沈阳药科大学博士药学院
2004.09 – 2008.06
沈阳药科大学学士药学院

工作经历

2021.07 – 至今
中国药科大学
药学院，副教授
2015.07 – 2021.07
中国药科大学
药学院，讲师

荣誉奖项

暂无内容

A Dual Glutathione-Depleting Nanoparticle Loaded with Porcine Pancreatic Elastase for Neoadjuvant Chemotherapy of Triple Negative Breast Cancer

负载猪胰弹性蛋白酶的双谷胱甘肽消耗纳米粒用于三阴性乳腺癌的新辅助化疗

IF16

2026-01-260

PRE

Self-amplifying tumor-targeting nanoreactor for enhanced Immuno-Ferroptosis therapy in triple-negative breast cancer

自放大肿瘤靶向纳米反应器，用于增强三阴性乳腺癌的免疫-铁死亡疗法

Chemical Engineering Journal

IF13.2

2025-11-260

PRE

ROS-sensitive dihydroartemisinin prodrug amplify chemo-immunotherapy efficacy of doxorubicin by coordinating robust tumor cell immunogenic cell death and PD-L1 blockade

ROS敏感的青蒿素双氢青蒿素前药通过协调强效的肿瘤细胞免疫原性细胞死亡和PD-L1阻断，增强多柔比星化疗-免疫疗法的疗效

Chinese Chemical Letters

IF8.9

2025-05-160

PRE

Epithelioid sarcoma of the right palm with distant metastasis to the axillary lymph nodes: A case report

ASIAN JOURNAL OF SURGERY

IF3.8

2024-08-010

OAAI

Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology

革命性的癌症治疗: 用CRISPR/Cas9基因编辑技术增强car-t细胞治疗

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-02-2114

OAAI

Synchronous targeted delivery of TGF-ß siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment

Tgf-ß siRNA向基质细胞和肿瘤细胞的同步靶向递送通过全面重塑肿瘤微环境引发针对三阴性乳腺癌的强大抗肿瘤免疫

IF12.9

2023-10-0115

PRE

Self-assembled thioether-bridged paclitaxel-dihydroartemisinin prodrug for amplified antitumor efficacy-based cancer ferroptotic-chemotherapy

BIOMATERIALS SCIENCE

IF5.7

2023-01-017

PRE

Dual Targeting of Cancer Cells and MMPs with Self-Assembly Hybrid Nanoparticles for Combination Therapy in Combating Cancer

IF5.5

2021-11-2311

OAAI

Doxorubicin delivered by redox-responsive Hyaluronic Acid-Ibuprofen prodrug micelles for treatment of metastatic breast cancer

氧化还原响应性透明质酸-布洛芬前药胶束递送的阿霉素治疗转移性乳腺癌

CARBOHYDRATE POLYMERS

IF12.5

2020-10-0155

PREAI

Fibroblast activation protein-α-adaptive micelles deliver anti-cancer drugs and reprogram stroma fibrosis

IF5.1

2020-01-0120

PREAI

Sustained Release Bilayer Tablet of Ibuprofen and Phenylephrine Hydrochloride: Preparation and Pharmacokinetics in Beagle Dogs

布洛芬与盐酸伪麻黄碱双层缓释片的制备及在比格犬体内的药代动力学研究

AAPS PHARMSCITECH

IF4

2019-01-239

PREAI

Identification of key genes and associated pathways in KIT/PDGFRA wild-type gastrointestinal stromal tumors through bioinformatics analysis

MOLECULAR MEDICINE REPORTS

IF3.5

2018-09-056

OAAI

Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2018-07-0143

PREAI

Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells

由CD44-Targeted前药和智能脂质体组装而成的纳米平台，用于肿瘤微环境和癌细胞的双重靶向

IF16

2018-01-24210

PREAI

Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer

SCIENTIFIC REPORTS

IF3.9

2017-04-0674

OAAI

Denatured protein stabilized drug nanoparticles: tunable drug state and penetration across the intestinal barrier

JOURNAL OF MATERIALS CHEMISTRY B

IF5.7

2017-01-0113

PREAI

Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug-Adverse Event Association

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2016-08-2228

OAAI

Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy

IF9.1

2016-08-08391

OAAI

Severe Hypoglycemia in Users of Sulfonylurea Antidiabetic Agents and Antihyperlipidemics

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2016-01-1722

OAAI

Recent Advances in Platinum (IV) Complex-Based Delivery Systems to Improve Platinum (II) Anticancer Therapy

基于铂 (IV) 络合物的递送系统改善铂 (II) 抗癌治疗的最新进展

MEDICINAL RESEARCH REVIEWS

IF11.6

2015-08-1795

PREAI

研究方向

智能纳米制剂技术研究口服固体制剂研发与产业化Chai Z.D.透明质酸纳米粒递药效率纤维激活蛋白-α响应PEG化修饰透明质酸纳米粒递药Teng C.Yang L.Ren L.J.Yuan Z.Y.Xu S.Y.Cheng M.M.Yan Z.Qin C.Han X.P.*氧化还原响应性透明质酸-布洛芬前药胶束转移性乳腺癌治疗Zhang B.Y.Kuang Z.成纤维细胞活化蛋白-α适应性胶束抗癌药物递送基质纤维化重编程Yuan Z.YLin C.S.He W.Yang Y.透明质酸纳米粒肿瘤靶向CD44受体Wu M.M.Wang X.W.Shi W.X.Dong Y.Y.

H 指数:41论文数:142被引数:7,003

H 指数:27论文数:116被引数:2,509

H 指数:31论文数:109被引数:2,956

H 指数:23论文数:102被引数:3,353

H 指数:55论文数:336被引数:1.4万

H 指数:70论文数:602被引数:1.9万

H 指数:40论文数:149被引数:4,966

H 指数:51论文数:315被引数:1.0万

H 指数:10论文数:28被引数:573

H 指数:23论文数:102被引数:1,595